205 related articles for article (PubMed ID: 25927284)
1. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.
Gau DM; Lesnock JL; Hood BL; Bhargava R; Sun M; Darcy K; Luthra S; Chandran U; Conrads TP; Edwards RP; Kelley JL; Krivak TC; Roy P
Cell Cycle; 2015; 14(12):1884-92. PubMed ID: 25927284
[TBL] [Abstract][Full Text] [Related]
2. Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.
Coumans JV; Gau D; Poljak A; Wasinger V; Roy P; Moens PD
OMICS; 2014 Dec; 18(12):778-91. PubMed ID: 25454514
[TBL] [Abstract][Full Text] [Related]
3. Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer.
Smith-Beckerman DM; Fung KW; Williams KE; Auersperg N; Godwin AK; Burlingame AL
Mol Cell Proteomics; 2005 Feb; 4(2):156-68. PubMed ID: 15591324
[TBL] [Abstract][Full Text] [Related]
4. Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.
Crugliano T; Quaresima B; Gaspari M; Faniello MC; Romeo F; Baudi F; Cuda G; Costanzo F; Venuta S
Int J Biochem Cell Biol; 2007; 39(1):220-6. PubMed ID: 17005433
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
6. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer.
Zhang L; Zhou Q; Qiu Q; Hou L; Wu M; Li J; Li X; Lu B; Cheng X; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Oct; 18(1):144. PubMed ID: 31623606
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review.
Teixeira LA; Candido Dos Reis FJ
J Clin Pathol; 2020 Apr; 73(4):191-196. PubMed ID: 31719105
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.
Karve TM; Preet A; Sneed R; Salamanca C; Li X; Xu J; Kumar D; Rosen EM; Saha T
PLoS One; 2012; 7(6):e37697. PubMed ID: 22685544
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor activity of profilin requires a functional actin binding site.
Wittenmayer N; Jandrig B; Rothkegel M; Schlüter K; Arnold W; Haensch W; Scherneck S; Jockusch BM
Mol Biol Cell; 2004 Apr; 15(4):1600-8. PubMed ID: 14767055
[TBL] [Abstract][Full Text] [Related]
10. Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses.
Wang Z; Zhang J; Zhang Y; Deng Q; Liang H
Int J Mol Med; 2018 Dec; 42(6):3542-3550. PubMed ID: 30221688
[TBL] [Abstract][Full Text] [Related]
11. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration.
Wu N; Zhang W; Yang Y; Liang YL; Wang LY; Jin JW; Cai XM; Zha XL
Proteomics; 2006 Nov; 6(22):6095-106. PubMed ID: 17051635
[TBL] [Abstract][Full Text] [Related]
12. Methylation status and immunohistochemistry of BRCA1 in epithelial ovarian cancer.
Pradjatmo H; Dasuki D; Anwar M; Mubarika S; Harijadi
Asian Pac J Cancer Prev; 2014; 15(21):9479-85. PubMed ID: 25422243
[TBL] [Abstract][Full Text] [Related]
13. BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer.
Dann RB; DeLoia JA; Timms KM; Zorn KK; Potter J; Flake DD; Lanchbury JS; Krivak TC
Gynecol Oncol; 2012 Jun; 125(3):677-82. PubMed ID: 22406760
[TBL] [Abstract][Full Text] [Related]
14. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
[TBL] [Abstract][Full Text] [Related]
15. MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
Whicker ME; Lin ZP; Hanna R; Sartorelli AC; Ratner ES
BMC Cancer; 2016 Jul; 16():550. PubMed ID: 27465688
[TBL] [Abstract][Full Text] [Related]
16. Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer.
Radosa MP; Häfner N; Camara O; Diebolder H; Mothes A; Winzer H; Jansen L; Dürst M; Runnebaum IB
Int J Gynecol Cancer; 2011 Nov; 21(8):1399-406. PubMed ID: 21897273
[TBL] [Abstract][Full Text] [Related]
17. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion.
Mouneimne G; Hansen SD; Selfors LM; Petrak L; Hickey MM; Gallegos LL; Simpson KJ; Lim J; Gertler FB; Hartwig JH; Mullins RD; Brugge JS
Cancer Cell; 2012 Nov; 22(5):615-30. PubMed ID: 23153535
[TBL] [Abstract][Full Text] [Related]
18. Macrophage capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma.
Glaser J; Neumann MH; Mei Q; Betz B; Seier N; Beyer I; Fehm T; Neubauer H; Niederacher D; Fleisch MC
Biomed Res Int; 2014; 2014():379847. PubMed ID: 24804218
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Le Page C; Rahimi K; Rodrigues M; Heinzelmann-Schwarz V; Recio N; Tommasi S; Bataillon G; Portelance L; Golmard L; Meunier L; Tonin PN; Gotlieb W; Yasmeen A; Ray-Coquard I; Labidi-Galy SI; Provencher D; Mes-Masson AM
Gynecol Oncol; 2020 Feb; 156(2):377-386. PubMed ID: 31753525
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer.
Alsiary R; Brownhill SC; Brüning-Richardson A; Hutson R; Griffin N; Morrison EE; Bond J; Burchill SA; Bell SM
Gene; 2018 Sep; 672():34-44. PubMed ID: 29860064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
